Skip to content
AnalystLens

CACI International Quarterly Report for Q1 Ended Sep 30, 2023

Filing Date
Filed October 26, 2023
Period End
September 30, 2023
Security
CACI
In the record · 2016–202610-K1110-Q338-K122

CACI filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 122 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Feb ’16Feb ’16
  2. Material agreement8-K · Dec ’19Dec ’19
  3. Leadership change8-K · Oct ’22Oct ’22
  4. Leadership change8-K · Jun ’26Jun ’26

Summary

Summary of the 10-Q filed October 26, 2023. Cited figures are marked; the original filing is the authoritative source.

CACI International Inc reported results for the three months ended September 30, 2023, with revenues of $1.85 billiona, up from $1.61 billion a year earlier, a 15.2% increase the filing attributes primarily to new contract awards and growth on existing programs.

Department of Defense revenues rose 23.5% to $1.35 billionb, while federal civilian agency revenues declined 3.9% to $407.3 million. Income from operations was $137.3 million compared with $132.8 million, but net income fell to $86.0 million from $89.1 million, and diluted earnings per share were $3.76, flat with the prior year. Interest expense and other, net rose to $25.6 million from $16.2 million, which the company attributes to higher interest rates on outstanding debt.

Cash flow weakened. Net cash provided by operating activities was $70.1 millionc, down from $144.8 million, driven by $71.3 million in net unfavorable changes in operating assets and liabilities. Total debt principal rose to $1.80 billion from $1.70 billion, with the revolver balance at $625.0 million, and the company repurchased $140.4 million of common stock during the quarter.

Total backlog was $26.7 billiond, up 7.2% from $24.9 billion a year earlier, and remaining performance obligations were $10.3 billion. The filing also discloses ongoing litigation, including the Al Shimari case, in which a jury trial has been set for April 15, 2024.

The company states it is vigorously defending the suits and believes the lawsuits are completely without merit. The filing discloses that the Tax Cuts and Jobs Act provision on research and development cost capitalization is expected to decrease fiscal 2024 operating cash flows by $75.3 million.

Key Highlights

  1. Revenues rose 15.2% to $1.85 billion, driven by Department of Defense growth of 23.5% to $1.35 billion.
  2. Net income declined 3.5% to $86.0 million, while diluted EPS was $3.76, unchanged from the prior year.
  3. Operating cash flow fell to $70.1 million from $144.8 million, mainly due to $71.3 million in unfavorable working capital changes.
  4. Total backlog reached $26.7 billion, up 7.2% from $24.9 billion a year earlier, with funded backlog of $4.2 billion.
  5. Share repurchases totaled $140.4 million in the quarter, and $349.7 million remains authorized under the 2023 Repurchase Program.
  6. Total principal debt increased to $1.80 billion, including $625.0 million drawn on the revolving facility, and the company was in compliance with all financial covenants.
  7. The Al Shimari litigation has been set for a jury trial on April 15, 2024, and the company believes the lawsuits are without merit.

Financial Statements

Q1 FY2024 against Q1 FY2023

Line itemQ1 FY2024Q1 FY2023Change
Revenue$1.85B$1.61B+15.2%
SG&A Expenses$404.63M$382.08M+5.9%
Operating Expenses$1.71B$1.47B+16.3%
Operating Income$137.35M$132.80M+3.4%
Interest Expense$25.57M$16.19M+57.9%
Net Income$86.05M$89.13M−3.5%
EPS (Basic)$3.80$3.81−0.3%
EPS (Diluted)$3.76$3.760.0%
Shares Outstanding (Basic)22.65M23.42M−3.3%
Shares Outstanding (Diluted)22.89M23.68M−3.3%

Frequently Asked Questions

  1. Why did net income decline despite higher revenue?

    Income from operations rose to $137.3 million from $132.8 million, but interest expense and other, net increased to $25.6 million from $16.2 million, which the company attributes to higher interest rates on outstanding debt. Income taxes also fell, but pre-tax income declined to $111.8 million from $116.6 million, leaving net income at $86.0 million versus $89.1 million.

  2. What drove the decline in operating cash flow?

    Net cash provided by operating activities decreased $74.8 million, as a result of $71.3 million in net unfavorable changes in operating assets and liabilities driven by increased revenue volume and the timing of vendor payments, and a $25.1 million decrease in cash received from the MARPA receivables program.

  3. How much debt does the company carry and what are its key facilities?

    Total principal amount of long-term debt was $1.80 billion at September 30, 2023. The $3.2 billion Credit Facility includes a $1.975 billion revolving facility, of which $625.0 million was outstanding, and a $1.225 billion term loan, of which $1.17 billion was outstanding. The effective interest rate on outstanding borrowings was 4.92%.

  4. What is the status of the Al Shimari litigation?

    On October 2, 2023, the District Court entered an order setting the case for a jury trial on April 15, 2024. CACI filed a petition for a writ of mandamus with the Fourth Circuit on September 7, 2023 asking that the action be dismissed for lack of subject matter jurisdiction. The company is vigorously defending the case and believes the lawsuits are completely without merit.

  5. What is the outlook for the tax provision affecting future cash flows?

    A Tax Cuts and Jobs Act provision that requires capitalizing and amortizing domestic research and development costs over five years is expected to decrease fiscal 2024 cash flows from operations by $75.3 million. The company notes that Congress could amend or repeal the provision, potentially with retroactive effect.